United Therapeutics buy tamam
Start price
31.08.17
/
50%
€116.65
Target price
03.06.19
€150.63
Performance (%)
-35.27%
End price
03.06.19
€75.51
Summary
This prediction ended on 03.06.19 with a price of €75.51. The BUY prediction by tamam for United Therapeutics performed very badly with a performance of -35.27%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| United Therapeutics | -0.634% | -0.634% | 89.478% | 132.632% |
| iShares Core DAX® | -0,37 % | 8,40 % | 6,76 % | 47,91 % |
| iShares Nasdaq 100 | 2,27 % | 15,23 % | 36,18 % | 94,08 % |
| iShares Nikkei 225® | 1,43 % | 14,42 % | 43,11 % | 64,80 % |
| iShares S&P 500 | 1,22 % | 10,49 % | 27,28 % | 66,76 % |
Comments by tamam for this prediction
In the thread United Therapeutics diskutieren
tamam stimmt dem Crowdsentiment von 'Buy' zu
tamam stimmt am 31.08.2017 dem Buy-Crowdsentiment mit dem Kursziel 167.0$ zu.
Eine Kurserholung drängt sich auf, da die
FDA rejects SteayMed's marketing application for lead candidate Trevyent for PAH!
(Vom Mitglied beendet)